News Releases Archives - Digipath Inc. - When Science Matters

GroSciences moves forward with TERP+ Broadspectum, a cannabis based all-natural pesticide.

Digipath’s GroSciences Moving Forward with Further Testing for its Patent Pending All-Natural, Plant-Derived Pesticide

BOULDER, CO, August 14, 2019 – Digipath, Inc. (OTCQB: DIGP), a service-oriented independent testing laboratory, data analytics and formulation firm focused on the developing cannabis and hemp markets, is pleased to announce that its GroSciences division has successfully completed preliminary validation testing on its patent pending all-natural, plant-derived pesticide, TERPO+ Broadspectrum. The product could potentially

Continue Reading

Letter to shareholders

Office of the CEO December 29, 2015 Fellow DigiPath Shareholders: It has been a year of tremendous progress for DigiPath, Inc. In 2015 we successfully opened our first cannabis testing facility, gained an audience of hundreds of thousands for our cannabis media outlet, and restructured our business units to focus entirely on this rapidly expanding

Continue Reading

Letter to Shareholders

From the Office of the CEO April 13, 2015 Fellow DigiPath Shareholders: We expect to open our first cannabis analytical testing laboratory in just a few short weeks, and it looks like we’ll be one of the first labs to open in Nevada. As we help usher medicinal marijuana into the Silver State, I wanted

Continue Reading